(PDF) Antidiabetic PPARgamma-Activator Rosiglitazone

Antidiabetic PPARgamma-Activator Rosiglitazone Reduces MMP-9 Serum Levels in Type 2 Diabetic Patients With Coronary Artery Disease

Arteriosclerosis, Thrombosis, and Vascular Biology - United States

doi 10.1161/01.atv.0000054195.35121.5e

Full Text

Abstract

Available in full text

Categories

Cardiovascular Medicine

Date

December 26, 2002

Authors

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Overexpression of Heart-Type Fatty Acid Binding Protein Enhances Fatty Acid-Induced Podocyteï¿½injury

Experimental and Therapeutic Medicine

Cancer Research

English

Role of Heart-Type Fatty Acid Binding Protein in the Brain Function

Yakugaku Zasshi

Pharmaceutical Science

English

Heart-Type Fatty Acid Binding Protein Versus Cardiac Troponin I in Early Detection of Myocardial Injury Induced by Scorpion Sting

The Egyptian Journal of Forensic Sciences and Applied Toxicology

English

Serum 99th Centile Values for Two Heart-Type Fatty Acid Binding Protein Assays

Annals of Clinical Biochemistry

Clinical Biochemistry

English

Fatty Acid Transport and Fatty Acid-Binding Proteins

Proceedings of the Nutrition Society

English

Heart-Type Fatty Acid Binding Protein Levels in Elderly Diabetics Without Known Cardiovascular Disease

Clinical Interventions in Aging

English

Kinetics of Fatty Acid Interactions With Fatty Acid Binding Proteins From Adipocyte, Heart, and Intestine

Journal of Biological Chemistry

Molecular Biology

English

Liver Fatty Acid-Binding Protein and Obesity

Journal of Nutritional Biochemistry

Molecular Biology

Clinical Biochemistry

English

FABP7 (Fatty Acid Binding Protein 7, Brain)

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Cancer Research

English

Pharmacological and Genetic Inhibition of Fatty Acid‐binding Protein 4 Alleviated Cisplatin‐induced Acute Kidney Injury

Journal of Cellular and Molecular Medicine

Molecular Medicine

English